Vaxart, Inc. (OTCQB: VXRT) has appointed Raquel "Rocky" C. Bono, M.D., a retired U.S. Navy Vice Admiral, to its board of directors, according to a company statement.

Dr. Bono's appointment follows a cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She will serve as Chair of the Stockholder Engagement Committee and as a member of the Nominating and Governance Committee and the Clinical and Regulatory Affairs Committee.

Dr. Bono is a board-certified trauma surgeon who previously served as Director of the Defense Health Agency, where she oversaw a $50 billion integrated global healthcare system serving 9.5 million beneficiaries. During the COVID-19 pandemic, she served as Director of Washington State's Pandemic Health System Response. She subsequently served as Chief Health Officer of Viking Cruises (NYSE: VIK) and currently serves on the board of Humana Inc. (NYSE: HUM). She is also Managing Partner of NAVA Edge LLC.

Dr. Bono holds a B.A. from the University of Texas at Austin, an M.D. from Texas Tech University Health Sciences Center, and an M.B.A. from Washington State University.

Vaxart is a clinical-stage biotechnology company developing oral recombinant vaccines, with current programs targeting coronavirus, norovirus, influenza, and human papillomavirus.